[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2556074T3 - Tricykliczny związek indazolowy, sposób jego wytwarzania i kompozycja farmaceutyczna zawierająca ten związek - Google Patents

Tricykliczny związek indazolowy, sposób jego wytwarzania i kompozycja farmaceutyczna zawierająca ten związek

Info

Publication number
PL2556074T3
PL2556074T3 PL11708766T PL11708766T PL2556074T3 PL 2556074 T3 PL2556074 T3 PL 2556074T3 PL 11708766 T PL11708766 T PL 11708766T PL 11708766 T PL11708766 T PL 11708766T PL 2556074 T3 PL2556074 T3 PL 2556074T3
Authority
PL
Poland
Prior art keywords
preparation
pharmaceutical composition
composition containing
indazole compound
tricyclic indazole
Prior art date
Application number
PL11708766T
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Nicola Cazzolla
Guido Furlotti
Beatrice Garrone
Gabriele Magaro'
Giorgina Mangano
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of PL2556074T3 publication Critical patent/PL2556074T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL11708766T 2010-04-08 2011-03-04 Tricykliczny związek indazolowy, sposób jego wytwarzania i kompozycja farmaceutyczna zawierająca ten związek PL2556074T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10159346 2010-04-08
EP20110708766 EP2556074B1 (en) 2010-04-08 2011-03-04 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
PCT/EP2011/053270 WO2011124430A1 (en) 2010-04-08 2011-03-04 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it

Publications (1)

Publication Number Publication Date
PL2556074T3 true PL2556074T3 (pl) 2015-06-30

Family

ID=42664839

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11708766T PL2556074T3 (pl) 2010-04-08 2011-03-04 Tricykliczny związek indazolowy, sposób jego wytwarzania i kompozycja farmaceutyczna zawierająca ten związek

Country Status (26)

Country Link
US (2) US9120801B2 (pl)
EP (1) EP2556074B1 (pl)
JP (1) JP5739980B2 (pl)
KR (1) KR20130045239A (pl)
CN (1) CN102812028B (pl)
AR (1) AR080835A1 (pl)
AU (1) AU2011238054B2 (pl)
BR (1) BR112012023539A2 (pl)
CA (1) CA2788762C (pl)
CY (1) CY1116246T1 (pl)
DK (1) DK2556074T3 (pl)
EA (1) EA021417B1 (pl)
ES (1) ES2532534T3 (pl)
GE (1) GEP20135997B (pl)
HK (1) HK1179962A1 (pl)
HR (1) HRP20150325T1 (pl)
IL (1) IL221244A (pl)
MX (1) MX2012011231A (pl)
PL (1) PL2556074T3 (pl)
PT (1) PT2556074E (pl)
RS (1) RS53859B1 (pl)
SG (1) SG183168A1 (pl)
SI (1) SI2556074T1 (pl)
SM (1) SMT201500066B (pl)
UA (1) UA108747C2 (pl)
WO (1) WO2011124430A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016201649A (ja) * 2015-04-09 2016-12-01 キヤノン株式会社 撮像装置、撮像システム、および撮像装置の駆動方法
KR20240135687A (ko) 2017-06-20 2024-09-11 임브리아 파마슈티칼스, 인크. 심장 대사의 효율을 증가시키기 위한 조성물 및 방법
CN109336890B (zh) * 2018-11-17 2020-03-20 重庆文理学院 一种吲唑类衍生物的合成方法及抗肿瘤应用
CA3131881A1 (en) * 2019-03-13 2020-09-17 Daisuke Tomita Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057213A2 (en) * 2001-12-28 2003-07-17 Bayer Pharmaceuticals Corporation Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
DE102004054665A1 (de) * 2004-11-12 2006-05-18 Bayer Cropscience Gmbh Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende

Also Published As

Publication number Publication date
MX2012011231A (es) 2012-11-12
WO2011124430A1 (en) 2011-10-13
EA021417B1 (ru) 2015-06-30
ES2532534T3 (es) 2015-03-27
US20150320763A1 (en) 2015-11-12
CA2788762C (en) 2018-04-10
SI2556074T1 (sl) 2015-04-30
HK1179962A1 (en) 2013-10-11
CN102812028B (zh) 2014-11-12
AU2011238054A1 (en) 2012-08-23
CY1116246T1 (el) 2017-04-26
HRP20150325T1 (hr) 2015-04-24
KR20130045239A (ko) 2013-05-03
IL221244A (en) 2016-02-29
RS53859B1 (en) 2015-08-31
GEP20135997B (en) 2013-12-25
PT2556074E (pt) 2015-03-04
JP2013523790A (ja) 2013-06-17
UA108747C2 (uk) 2015-06-10
AR080835A1 (es) 2012-05-09
AU2011238054B2 (en) 2016-06-23
SMT201500066B (it) 2015-05-05
JP5739980B2 (ja) 2015-06-24
EA201291014A1 (ru) 2013-03-29
US9655906B2 (en) 2017-05-23
EP2556074B1 (en) 2015-01-21
EP2556074A1 (en) 2013-02-13
CA2788762A1 (en) 2011-10-13
US9120801B2 (en) 2015-09-01
DK2556074T3 (en) 2015-03-23
SG183168A1 (en) 2012-09-27
US20130023524A1 (en) 2013-01-24
CN102812028A (zh) 2012-12-05
IL221244A0 (en) 2012-10-31
BR112012023539A2 (pt) 2017-10-03

Similar Documents

Publication Publication Date Title
IL222199A0 (en) Process for preparation of dopo-derived compounds and compositions thereof
HK1199255A1 (en) Indazole compounds, compositions and methods of use
IL230218A (en) Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
ZA201303988B (en) Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
EP2582664A4 (en) PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE
HK1179962A1 (en) Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
EP2924042A4 (en) BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
PL2281822T3 (pl) Nowe pochodne dihydroindolonów, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL231505B (en) Pharmaceutical preparation and method for its production
PL2504331T3 (pl) Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
IL230219B (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
EP2701689A4 (en) PHARMACEUTICAL COMPOSITIONS OF RALTEEGRAVIR, METHODS OF PREPARATION AND USE THEREOF
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL230907A0 (en) Salt and formations of a pyrazolopyrimidine compound, a medical composition that includes the above, and a preparation and use process for them
HUP1100532A2 (en) Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them
EP2565180A4 (en) ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION THEREWITH
IL225378A0 (en) History of phenylquinazoline, their preparation and pharmaceutical preparations containing them
IL208957A0 (en) Pharmaceutical gallium compounds, composition and methods of preparation
EP2543373A4 (en) PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND
PL2497774T3 (pl) Pochodne dihydro-oksazolobenzodiazepinonu, sposoby ich wytwarzania i kompozycje farmaceutyczne zawierające te związki
PL2407159T3 (pl) Kompozycje farmaceutyczne olmesartanu
HU1000591D0 (en) Stabilized pharmaceutical compositions containing capsaicin and process for their preparation
HU1000455D0 (en) Solid composition for killing slugs and process for its preparation